White House Press Secretary on Vaccine Distribution

Don Tran
By Don Tran
December 16, 2020NTD Evening News
share

In a White House briefing, the White House press secretary Kayleigh McEnany outlined achievements the Trump Administration made to get the CCP virus vaccine out to the American People. She also gave an update on when the president will take the vaccine himself.

At the beginning of the briefing, McEnany noted several reports by mainstream media that cast doubt on vaccine development and distribution.

Under Operation Warp Speed, the Trump Administration mobilized the Defense Department and the Department of Health and Human Services to make sure vaccines and equipment are promptly delivered.

The administration also gave funding and technical support through the National Institute for Allergy and Infectious Diseases and Biomedical Advanced Research and Development Authority.

“The results of these historic investments will benefit the American people and will mark the beginning of the end of the pandemic. As the first doses of the vaccine are delivered and administered, we urge all Americans to continue to wash your hands, socially distance, wear a mask when you are unable to do so,” said McEnany.

When asked whether or not President Trump would take the vaccine, and if he’ll do it publicly to inspire confidence to the people.

McEnany said the president is absolutely open to taking it.

“He will receive the vaccine as soon as his medical team determines it’s best, but his priority is frontline workers, those in long-term care facilities, and he wants to make sure the vulnerable get access first,” said McEnany.

According to the White House, around 3 million doses of Pfizer vaccines have been distributed, and an additional amount will be rolling out in 21 days.

The FDA said vaccine data from Moderna looks good, and the White House hopes it gets approval for emergency use authorization.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments